Victor W. Li

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Utilizing Apple Vision Pro for Mindfulness Intervention to Reduce Pain and Anxiety in a Hospitalized Patient With Mixed Connective Tissue Disease: A Case Report.

Utilizing Apple Vision Pro for Mindfulness Intervention to Reduce Pain and Anxiety in a Hospitalized Patient With Mixed Connective Tissue Disease: A Case Report.

Journal: Cureus

Published: April 24, 2026

Patient Attitudes About Light Therapy and Negative Ion Therapy for Nonseasonal Depression: An Online Survey Study.

Patient Attitudes About Light Therapy and Negative Ion Therapy for Nonseasonal Depression: An Online Survey Study.

Journal: Cureus

Published: November 29, 2025

24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review.

24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review.

Journal: Addiction science & clinical practice

Published: May 29, 2025

The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal.

The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal.

Journal: Addiction biology

Published: May 03, 2025

Lithium as a disease-modifying drug for bipolar disorder.

Lithium as a disease-modifying drug for bipolar disorder.

Journal: The lancet. Psychiatry

Published: January 22, 2025

Direct Induction of Buprenorphine Extended-Release: A Case Report.

Direct Induction of Buprenorphine Extended-Release: A Case Report.

Journal: Journal of addiction medicine

Published: January 09, 2025

Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 study.

Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 study.

Journal: Journal of affective disorders

Published: December 20, 2024

24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.

24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.

Journal: Journal of psychoactive drugs

Published: November 19, 2024

Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report.

Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report.

Journal: Addiction science & clinical practice

Published: October 03, 2024

Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy.

Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy.

Journal: Frontiers in psychiatry

Published: September 23, 2024

A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépression.

A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépression.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: April 11, 2024

Systematic review on intentional non-medical fentanyl use among people who use drugs.

Systematic review on intentional non-medical fentanyl use among people who use drugs.

Journal: Frontiers in psychiatry

Published: December 01, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026